Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2021-01-28
DOI
10.1080/0284186x.2021.1876246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P-253Age vs performance status - which is worst for surgery outcome?
- (2019) E Amorim et al. ANNALS OF ONCOLOGY
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
- (2018) Aliya Noor Husain et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients – A Taiwanese study
- (2018) Ting-Hui Wu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Non-occupational exposure to asbestos is the main cause of malignant mesothelioma in women in North Jutland, Denmark
- (2018) Vasiliki Panou et al. SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH
- New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
- (2018) Marika Rossini et al. Frontiers in Oncology
- Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis
- (2017) Gary M Marsh et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma
- (2017) Manlio Mencoboni et al. Oncology Research and Treatment
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
- (2016) David Rice et al. Journal of Thoracic Oncology
- Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
- (2016) Gérard Zalcman et al. LANCET
- The established and future biomarkers of malignant pleural mesothelioma
- (2015) V. Panou et al. CANCER TREATMENT REVIEWS
- Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
- (2014) A Linton et al. BRITISH JOURNAL OF CANCER
- Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials
- (2014) Aaron S. Mansfield et al. LUNG CANCER
- Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data
- (2013) Emily Goswami et al. International Journal of Environmental Research and Public Health
- Treatment and survival analyses of malignant mesothelioma in Japan
- (2012) Kenichi Gemba et al. ACTA ONCOLOGICA
- Prognosis and prognostic factors of patients with mesothelioma: a population-based study
- (2012) S van der Bij et al. BRITISH JOURNAL OF CANCER
- Postmortem Findings of Malignant Pleural Mesothelioma
- (2012) Rhian S. Finn et al. CHEST
- The Supplementary Pension Fund Register
- (2011) Johnni Hansen et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- The Danish Cancer Registry
- (2011) Marianne Lundkjær Gjerstorff SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- The Danish National Patient Register
- (2011) Elsebeth Lynge et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- The Danish Civil Registration System
- (2011) Carsten Bøcker Pedersen SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data
- (2010) Azza M. Adel et al. Thoracic Cancer
- Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma
- (2009) Guntulu Ak et al. Journal of Thoracic Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation